WinstonWınston
Back
Gielda Praw Majatkowych Vindexus Spolka Akcyjna logo

Gielda Praw Majatkowych Vindexus Spolka Akcyjna

VIN.WA
53
Specialty Business Services · Industrials
Exchange
Warsaw Stock Exchange
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Strong
Growth
Weak
Cash Flow
Weak
Stability
Strong
Valuation
Good
Dividends
Exceptional

Winston Score History

The full picture

Vindexus is a Polish company that buys unpaid debts from banks, telecom companies, and other businesses at a discount. The original lenders no longer want to chase these debts, so Vindexus purchases the debt portfolios outright and then collects the money owed from individual borrowers. It operates in the debt purchasing and collection industry in Poland.

The company makes money by collecting more cash from borrowers than it paid for the debt portfolios — the difference is its profit. Vindexus is a smaller player focused entirely on the Polish market, with a market cap of around $0.2 billion. Its high operating margin near 49% suggests efficient collections operations, and its moat comes from experience valuing and managing debt portfolios, which requires specialized legal and analytical skills. The main risk is that rising interest rates or economic downturns can make it harder for borrowers to repay, which reduces the value of purchased debt portfolios and squeezes future returns.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
51.2%
Healthy — 51.2% gross margin
Profit after running costs
Operating Margin
47.6%
Excellent — 47.6% operating margin
Return on the money invested
ROCE
12.5%
Good — 12.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-15.6%
Shrinking sales (-15.6% YoY)
Profit growth
EPS YoY
+5.6%
Modest earnings growth (+5.6% YoY)

Single-digit earnings growth — steady but not exciting.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
-176%
Weak — only -176% of profit becomes cash
Spare cash per sale
FCF Margin
-46.3%
Burning cash (-46.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.43
Conservative — low debt load (0.43)
Covers its interest
Interest Cover
4.42x
Adequate interest coverage (4.4x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
6.5x
no trend
Attractive valuation — P/E 6.5

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
-2.0
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
7.38%
no trend
Healthy income — 7.38% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record
Dividend Growth
+56.9%
no trend
Dividend growing fast (56.9% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial